JPWO2023108159A5 - - Google Patents
Info
- Publication number
- JPWO2023108159A5 JPWO2023108159A5 JP2024534647A JP2024534647A JPWO2023108159A5 JP WO2023108159 A5 JPWO2023108159 A5 JP WO2023108159A5 JP 2024534647 A JP2024534647 A JP 2024534647A JP 2024534647 A JP2024534647 A JP 2024534647A JP WO2023108159 A5 JPWO2023108159 A5 JP WO2023108159A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- seq
- raav
- sequence
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163288520P | 2021-12-10 | 2021-12-10 | |
| US63/288,520 | 2021-12-10 | ||
| PCT/US2022/081323 WO2023108159A1 (en) | 2021-12-10 | 2022-12-09 | Methods and compositions for treating bag-3 related cardiomyopathy with a viral vector |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024545183A JP2024545183A (ja) | 2024-12-05 |
| JPWO2023108159A5 true JPWO2023108159A5 (https=) | 2025-12-17 |
| JP2024545183A5 JP2024545183A5 (https=) | 2025-12-17 |
Family
ID=86731334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534647A Pending JP2024545183A (ja) | 2021-12-10 | 2022-12-09 | ウイルスベクターによりｂａｇ－３関連心筋症を処置するための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250041453A1 (https=) |
| EP (1) | EP4444364A1 (https=) |
| JP (1) | JP2024545183A (https=) |
| KR (1) | KR20240118855A (https=) |
| AU (1) | AU2022407655A1 (https=) |
| CA (1) | CA3242351A1 (https=) |
| IL (1) | IL313427A (https=) |
| WO (1) | WO2023108159A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3254775A1 (en) * | 2022-03-18 | 2023-09-21 | University Of Florida Research Foundation, Incorporated | METHODS AND COMPOSITIONS FOR TREATING TNNT2-RELATED CARDIOMYOPATHY WITH A VIRAL VECTOR |
| EP4665749A1 (en) * | 2023-02-13 | 2025-12-24 | Astrazeneca Ireland Limited | Nucleic acids encoding bcl2-associated athanogene 3 (bag3) for gene therapy |
| WO2024215655A1 (en) * | 2023-04-10 | 2024-10-17 | Tenaya Therapeutics, Inc. | Cardioprotective bag3 therapies |
| AU2024265705A1 (en) * | 2023-05-02 | 2025-11-20 | Research Institute At Nationwide Children's Hospital | Gene therapy for treatment of protein misfolding diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3099333B8 (en) * | 2014-01-31 | 2020-12-30 | Temple University of the Commonwealth System of Higher Education | Bag3 as a target for therapy of heart failure |
| WO2015153889A2 (en) * | 2014-04-02 | 2015-10-08 | University Of Florida Research Foundation, Incorporated | Materials and methods for the treatment of latent viral infection |
| EP3452101A2 (en) * | 2016-05-04 | 2019-03-13 | CureVac AG | Rna encoding a therapeutic protein |
| US20190328836A1 (en) * | 2017-01-09 | 2019-10-31 | Duke University | Methods for treating ischemic injury |
| KR20210112339A (ko) * | 2019-01-04 | 2021-09-14 | 울트라제닉스 파마수티컬 인코포레이티드 | 윌슨병을 치료하기 위한 유전자 요법 구축물 |
| WO2021154923A2 (en) * | 2020-01-29 | 2021-08-05 | Voyager Therapeutics, Inc. | Methods and systems for producing aav particles |
-
2022
- 2022-12-09 KR KR1020247023092A patent/KR20240118855A/ko active Pending
- 2022-12-09 EP EP22905439.0A patent/EP4444364A1/en active Pending
- 2022-12-09 US US18/717,532 patent/US20250041453A1/en active Pending
- 2022-12-09 AU AU2022407655A patent/AU2022407655A1/en active Pending
- 2022-12-09 WO PCT/US2022/081323 patent/WO2023108159A1/en not_active Ceased
- 2022-12-09 JP JP2024534647A patent/JP2024545183A/ja active Pending
- 2022-12-09 IL IL313427A patent/IL313427A/en unknown
- 2022-12-09 CA CA3242351A patent/CA3242351A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220331409A1 (en) | Factor ix gene therapy | |
| JP7374119B2 (ja) | 減少した肝臓向性を有するＡＡＶ９とＡＡＶｒｈ７４とのハイブリッド組換えアデノ随伴ウイルス血清型 | |
| JP2025179046A5 (https=) | ||
| JP2022500066A5 (https=) | ||
| JP2023070682A5 (https=) | ||
| JP6573991B2 (ja) | 血管性浮腫の治療としてのｃ１ｅｉのアデノ随伴ウイルス介在性送達 | |
| JP2020518268A5 (https=) | ||
| JP2021531752A5 (https=) | ||
| JP2021533805A5 (https=) | ||
| JPWO2020069461A5 (https=) | ||
| JP2021500922A5 (https=) | ||
| JP2019524090A5 (https=) | ||
| JPWO2023108159A5 (https=) | ||
| JP2020510433A5 (https=) | ||
| JPWO2020223362A5 (https=) | ||
| JPWO2021226267A5 (https=) | ||
| JPWO2023108157A5 (https=) | ||
| US11517631B2 (en) | Factor IX encoding nucleotides | |
| JP2022514271A5 (https=) | ||
| JPWO2021108809A5 (https=) | ||
| JPWO2021076925A5 (https=) | ||
| JP2024528997A (ja) | 放射線誘発性唾液機能低下を予防するためのａｑｐ１遺伝子療法 | |
| JPWO2020038473A5 (https=) | ||
| JPWO2020237130A5 (https=) | ||
| JPWO2023178339A5 (https=) |